Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from Northeast Italy

Autor: Claudio Conforti, Eleonora Farinazzo, P Schincariol, Enzo Errichetti, N. de Manzini, N. Di Meo, G Ponis, Iris Zalaudek, Anna Moret, Ludovica Toffoli, Caterina Pinzani, Marina Agozzino, A Gambelli, Enrico Zelin, Giuseppe Stinco
Přispěvatelé: Farinazzo, E., Ponis, G., Zelin, E., Errichetti, E., Stinco, G., Pinzani, C., Gambelli, A., De Manzini, N., Toffoli, L., Moret, A., Agozzino, M., Conforti, C., Di Meo, N., Schincariol, P., Zalaudek, I.
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Journal of the European Academy of Dermatology and Venereology
Popis: We report the first registered cases of cutaneous adverse reactions in North-East Italy after the m-RNA COVID-19 vaccine Comirnaty®-BioNTech/Pfizer, During January 2021, in the public health jurisdiction of Trieste, a total of 19,485 individuals have been vaccinated: 13,266 (68.08%) first doses and 6,219 (31.92%) completed cycles of two doses. In this population, 266 (1.36%) adverse reactions have been reported to the Pharmacovigilance Service. Notably, one or more cutaneous adverse effects were present in 44 people, accounting for 0.22% of all vaccinated individuals and 16.54% of communicated adverse effects. The reactions included both those at the injection site and more extensive manifestations (Table 1).
Databáze: OpenAIRE